The Relationship between Serum Osteopontin level and Parameters of Chronic Kidney Disease – Mineral Bone Disease in Patients on Regular Hemodialysis

Bibliographic Information
Authors: Nawar A.M.; Elhendy Y.A.A.; Nabil M.; Sami M.M.; Salah A.M.; Allam H.M.
Journal: Egyptian Journal of Hospital Medicine
Publisher: Ain Shams University Faculty of Medicine
Publication Date: 1 January 2022
Volume / Issue: Volume 86 / Issue 1
Pages: 499–501
ISSN: 16872002
DOI: 10.21608/EJHM.2022.213805
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access
Authors and Affiliations
Nawar A.M., Theodor Bilharz Research Institute, Cairo, Egypt; Elhendy Y.A.A., Department of Internal Medicine and Nephrology, Faculty of Medicine, Zagazig University, Alsharquia, Egypt; Nabil M., Theodor Bilharz Research Institute, Cairo, Egypt; Sami M.M., Department of Clinical Pathology, Faculty of Medicine, Zagazig University, Alsharquia, Egypt; Salah A.M., Department of Internal Medicine and Nephrology, Faculty of Medicine, Zagazig University, Alsharquia, Egypt; Allam H.M., Department of Internal Medicine and Nephrology, Faculty of Medicine, Zagazig University, Alsharquia, Egypt
Abstract
Background: Chronic Kidney Disease (CKD) is becoming a major health concern worldwide. For many patients, CKD is associated with substantial morbidity and mortality. Osteopontin (OPN) is an extracellular matrix protein first identified in bone tissue and has pleiotropic functions due to its common expression in the main organs and apparatuses. It is a phosphorylated glycophosphoprotein composed of 314 amino acids, involved in biomineralization and remodeling. Objective: This research aimed to assess the serum level of osteopontin in patients with end-stage renal disease (ESRD) on regular haemodialysis and to correlate osteopontin level in patients with ESRD on hemodialysis with other biomarkers CKD-MBD. Patients & Methods: This Study was conducted on 160 participants that were divided into two groups. Control group included 80 healthy subjects of both sexes, and patients group that included 80 ESRD patients on regular hemodialysis of both sexes. All studied groups were subjected to osteopontin level by enzyme-linked immunosorbent assay (ELISA). Results: Serum osteopontin levels were higher in ESRD patients on regular dialysis than in healthy individuals, where it might have a higher predictive value for CKD development. Also, they were positively correlated with serum phosphorus, serum alkaline phosphatase and serum parathyroid hormone, which are parameters of chronic kidney disease-mineral and bone disorder. Conclusion: Osteopontin may be considered an early marker of chronic kidney disease. © 2022, Ain Shams University Faculty of Medicine. All rights reserved.
Keywords
Hemodialysis; Kidney; Osteopontin
Citation Information
Scopus Citations: 0
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
